Tone mix
Week by week 47 weeks
Share of Opus Genetics, Inc. Common Stock's 126 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of May 11, 2026 · tone -50Opus Genetics (NASDAQ:IRD) Releases Earnings Results, Misses Estimates By $0.59 EPS-80
- Week of Jul 27, 2026 · tone 0Opus Genetics, Inc. (NASDAQ:IRD) Receives $10.77 Average PT from Analysts-61
- Week of Mar 23, 2026 · tone 0Short Interest in Opus Genetics, Inc. (NASDAQ:IRD) Grows By 81.3%-56
- Week of Oct 26, 2026 · tone 0Opus Genetics (NASDAQ:IRD) vs. Alkermes (NASDAQ:ALKS) Financial Analysis-54
- Week of Jun 8, 2026 · tone +94Guggenheim Initiates Coverage Of Opus Genetics (IRD) With "Buy" Rating And $16 Price Target+53
- Week of Nov 24, 2025 · tone +100IRD surpasses Rs. 2 Trillion revenue landmark+50
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Opus Genetics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 7 | +14 |
| Last 30 sessions | 23 | +41 |
| Last 90 sessions | 52 | +45 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, November 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletOpus Genetics (IRD) Set to Post Quarterly Earnings on WednesdayNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Opus Genetics (IRD) Set to Post Quarterly Earnings on Wednesday | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletComparing Opus Genetics (IRD) and Its CompetitorsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Comparing Opus Genetics (IRD) and Its Competitors | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.manilatimes.net · 1 outletOpus Genetics to Present at the Guggenheim Annual Healthcare Innovation ConferenceNeutral
- www.manilatimes.net · 1 outletOpus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Opus Genetics to Present at the Guggenheim Annual Healthcare Innovation Conference | www.manilatimes.net | 1 | Neutral |
| Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletOpus Genetics, Inc. (NASDAQ:IRD) Stock Rated "Moderate Buy" by Wall Street BrokeragesPositive
- www.tickerreport.com · 1 outletOpus Genetics, Inc. (NASDAQ:IRD) Stock Has Average Target Price of $12.71Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Opus Genetics, Inc. (NASDAQ:IRD) Stock Rated "Moderate Buy" by Wall Street Brokerages | www.dailypolitical.com | 1 | Positive |
| Opus Genetics, Inc. (NASDAQ:IRD) Stock Has Average Target Price of $12.71 | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletOpus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive OperationsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Opus Genetics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.